Clearance Summary
REMEL SPARFLOXACIN 5G SUSCEPTIBILTY DISK received FDA 510(k) clearance under submission number K970831, sponsored by Remel, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Microbiology review panel. The statutory decision date of record is 1997-04-02.
- Submission: K970831
- Applicant / Sponsor: Remel, Inc.
- Clearance pathway: Traditional
- Review panel: Microbiology
- Device class: Class II
- Regulation citation: 21 CFR 866.1620
- Decision date: 1997-04-02
Classification & Regulation
This clearance is catalogued under FDA product code JTN and 21 CFR 866.1620, within the Microbiology review panel as a Class II device.